CA2100883A1 - Dosage immunologique a l'aide de peptides synthetiques du htlv-ii - Google Patents

Dosage immunologique a l'aide de peptides synthetiques du htlv-ii

Info

Publication number
CA2100883A1
CA2100883A1 CA 2100883 CA2100883A CA2100883A1 CA 2100883 A1 CA2100883 A1 CA 2100883A1 CA 2100883 CA2100883 CA 2100883 CA 2100883 A CA2100883 A CA 2100883A CA 2100883 A1 CA2100883 A1 CA 2100883A1
Authority
CA
Canada
Prior art keywords
sequence
htlv
solid phase
peptide
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2100883
Other languages
English (en)
Inventor
Dinesh O. Shah
Nrapendra Nath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dade International Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2100883A1 publication Critical patent/CA2100883A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
CA 2100883 1991-11-25 1992-11-20 Dosage immunologique a l'aide de peptides synthetiques du htlv-ii Abandoned CA2100883A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79755791A 1991-11-25 1991-11-25
US7/797,557 1991-11-25

Publications (1)

Publication Number Publication Date
CA2100883A1 true CA2100883A1 (fr) 1993-05-26

Family

ID=25171175

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2100883 Abandoned CA2100883A1 (fr) 1991-11-25 1992-11-20 Dosage immunologique a l'aide de peptides synthetiques du htlv-ii

Country Status (5)

Country Link
EP (1) EP0573630A4 (fr)
JP (1) JPH06506479A (fr)
AU (1) AU660752B2 (fr)
CA (1) CA2100883A1 (fr)
WO (1) WO1993011431A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69330164T2 (de) * 1992-02-24 2002-01-17 Genelabs Tech Inc Htlv-i/htlv-ii assay und verfahren
US7166439B2 (en) * 2002-03-01 2007-01-23 Gmp Endotherapeutics, Inc. Assay for anti-INGAP antibodies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070246A (en) * 1976-04-09 1978-01-24 Abbott Laboratories Reactive matrices
US4070247A (en) * 1977-03-30 1978-01-24 Indiana University Foundation Diagnostic media
US5039604A (en) * 1987-08-21 1991-08-13 Cellular Products, Inc. Test device and method of preparing same, assay kit and method for the simultaneous detection of two HTLV or HIV antibodies
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
SE8900721D0 (sv) * 1989-03-02 1989-03-02 Blomberg Jonas Methods for detection of antibodies to
FI910245A (fi) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot htlv-antikroppar.
NZ238855A (en) * 1990-07-18 1994-03-25 Iaf Biochem Int Peptides, mixtures thereof and compositions useful for detecting htlv-i and htlv-ii infections

Also Published As

Publication number Publication date
AU660752B2 (en) 1995-07-06
WO1993011431A1 (fr) 1993-06-10
EP0573630A1 (fr) 1993-12-15
JPH06506479A (ja) 1994-07-21
EP0573630A4 (fr) 1995-07-12
AU3142593A (en) 1993-06-28

Similar Documents

Publication Publication Date Title
CA2102301C (fr) Procede de dosage de peptides correspondant a des epitopes immunologiquement importants et leur utilisation dans un procede de dosage d'anticorps ou peptides biotinyles correspondant a des epitopes immunologiquement importants, procede pour leur preparation et compositions en contenant
CA2054798C (fr) Peptides specifique du vhc, leurs agents et leur utilisation
JP2994031B2 (ja) Ｈｉｖ−１又はｈｉｖ−２抗体の存在又は量の確定方法、免疫特異的試薬、合成ペプチド、診断用キット、ｈｉｖ−１又はｈｉｖ−２抗体の調製方法、免疫原及び抗体
US5260189A (en) Synthetic HIV-like peptides their compositions and uses
EP0247557B1 (fr) Peptides enveloppé HTLV-III(LAV)
Marsden et al. Identification of an immunodominant sequential epitope in glycoprotein G of herpes simplex virus type 2 that is useful for serotype‐specific diagnosis
SE467542B (sv) Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
CA2100883A1 (fr) Dosage immunologique a l'aide de peptides synthetiques du htlv-ii
AU746231B2 (en) Reagent for detecting and monitoring viral infections
US5283320A (en) Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom
CA2090470A1 (fr) Antigenes peptidiques et dosages immunologiques, trousses d'essais et vaccins
JP3560987B2 (ja) グループｏ ｈｉｖ−１ウイルスによる感染検出用の生物学的アッセイに有用な合成ペプチド
AU657590B2 (en) Synthetic peptides corresponding to portions of HIV-2 virus and methods of using in an improved assay
JP2002501930A (ja) ペプチド構造物およびそれらの単純ヘルペスウイルス２型の診断における使用
JP2655205B2 (ja) 非ａ非ｂ肝炎のアッセイ
JP2002511853A (ja) Ｈｉｖ抗体の検出方法及びそれに使用する抗原
AU614971B2 (en) Hiv polypeptide, its preparation and use in detection of hiv antibodies
JP2007224043A (ja) ペプチド構造物およびそれらの単純ヘルペスウイルス２型の診断における使用
WO1992007961A1 (fr) Detection specifique d'anticorps contre les virus du syndrome immunodeficitaire acquis

Legal Events

Date Code Title Description
FZDE Dead